Preparedness to production: a Canadian perspective on building industrial capacity for health emergency readiness

Vaccine Insights 2025; 4(9), 373–382

DOI: 10.18609/vac.2025.052

Published: 9 December
Commentary
Taylor Caminiti, Aaya Mahdi, Sydney Raduy, Alexandra G Vasiliu, Lynn Berrouard, Fern Bannatyne, Juan Esteban

This article examines Canada’s efforts to rebuild biomanufacturing capacity and industrial readiness for future health emergencies. Specifically, the authors discuss efforts from the federal Innovation, Science and Economic Development (ISED) Portfolio intended to boost domestic vaccine development and manufacturing. The article also outlines the establishment of Health Emergency Readiness Canada in 2024 as a special operating agency tasked with capability mapping, partnership development, and maintenance of protocols to coordinate industrial mobilization during emergencies. Finally, these initiatives are related to international preparedness goals, including CEPI’s 100 Days Mission.

}